CompletedNCT00780208

Evaluating the Methylphenidate Patch to Treat Former Stimulant Users With ADHD

Medication studyAges 18–65United States

The study in practice

Understand this study

Listed age limits: 18 years to 65 years.

Listed locations: Charleston, United StatesSee all locations and recruitment
Activities: Medication described in the protocol
Compensation: Payment and expense reimbursement have not been verified.

Study clarity

Study start dateApril 2007

Recruitment status: Completed
Enrollment listed in the registry: 14
Sponsor: Medical University of South Carolina
Sponsor type: University
Study type: Drug
Intervention type: Medication / drug
Study phase: Not clearly listed
Locations: United States
Age range: From 18 Years to 65 Years
Official registry ID: NCT00780208
Official title: Show the full official title
The Evaluation of the Safety and Efficacy of the Methylphenidate Patch in Former Stimulant Users With ADHD

Completed

Charleston

FAQ

Who is behind this study?

The study sponsor is Medical University of South Carolina, a university.

Did this study involve medication?

Yes. The study involved medication, including Daytrana (methylphenidate patch).

Who was this study for?

Listed age limits: 18 years to 65 years.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.